Camlin Fine Sciences plans to set up a wholly owned subsidiary in Canada for undertaking trading and distribution of antioxidants, food ingredients, blends and formulations in the US and Canadian markets. The company, however, did not disclose financial details or any other information about the proposed subsidiary. The stock on Monday closed three per cent lower at ₹22.65.